🟠 Moderate Evidence
Extra virgin olive oil consumption of approximately 20–30 grams daily is associated with substantially lower cancer mortality and all-cause mortality in large prospective cohorts, according to data from the Moli-Sani Study, which tracked nearly 23,000 adults over 12 years. The protective effect appears to be mediated by polyphenolic compounds, particularly hydroxytyrosol, which the European Food Safety Authority (EFSA) has determined to have sufficient evidence for cardiovascular protection.
Key takeaways
- Participants consuming ~30 g/day of olive oil experienced approximately 28% lower cancer mortality and 18% lower all-cause mortality over 12 years
- Benefits were associated with daily intake of at least 5 mg of hydroxytyrosol and related polyphenolic compounds
- Effects remained significant after adjustment for diet quality, lifestyle, and socioeconomic factors, suggesting independent protective mechanisms
- Extra virgin, cold-pressed oils retain higher polyphenol content than refined varieties
Study at a Glance
| Source | Moli-Sani prospective cohort study |
| Study type | Prospective cohort with 12-year follow-up |
| Sample size | N ≈ 23,000 adults |
| Population | Community-dwelling adults in Southern Italy |
| Country | Italy |
Mortality Benefits Associated with Olive Oil Consumption
Relative risk reduction among participants consuming ~30 g/day versus lower intakes, Moli-Sani Study (n≈23,000, 12-year follow-up)
Source: Moli-Sani Study data | Georgian Medical Journal News
Long-term cohort evidence supports cardiovascular and cancer protection
The Moli-Sani Study, a large prospective Italian cohort, enrolled approximately 23,000 community-dwelling adults and followed them for 12 years with detailed dietary and health outcome assessment. Among participants consuming approximately 30 grams of olive oil daily—roughly equivalent to 2–3 tablespoons—researchers documented a 28% lower risk of cancer mortality and an 18% lower risk of all-cause mortality compared with lower consumption groups.
Importantly, these protective associations remained statistically significant even after researchers adjusted for overall diet quality, physical activity, smoking status, and socioeconomic factors. This suggests that olive oil’s benefits extend beyond general healthy dietary patterns. The study also found that observed benefits were strongest in non-obese participants, indicating that metabolic status may influence the magnitude of olive oil’s protective effects.
Polyphenols, particularly hydroxytyrosol, explain the protective mechanism
The cardioprotective and anti-cancer properties of olive oil are predominantly attributable to its polyphenolic compounds. The European Food Safety Authority (EFSA) evaluated the evidence base and approved a specific health claim: a daily intake of 20 grams of olive oil containing at least 5 milligrams of hydroxytyrosol and related compounds helps protect low-density lipoprotein (LDL) cholesterol from oxidative damage. Oxidative modification of LDL is a critical early step in atherosclerosis development.
Randomized controlled trials published in peer-reviewed journals demonstrate that olive oil polyphenols improve lipid profiles by lowering LDL cholesterol and raising protective high-density lipoprotein (HDL) cholesterol. Additionally, meta-analyses show consistent reductions in inflammatory markers such as C-reactive protein (CRP), a systemic inflammation indicator linked to cardiovascular disease, cancer progression, and cognitive decline. These mechanistic pathways explain how olive oil consumption translates into the observed mortality reductions documented in the Moli-Sani and other large cohort studies.
Selection and application: maximizing polyphenol retention
The polyphenol content of olive oil varies significantly depending on production methods. Extra virgin, cold-pressed olive oils retain substantially higher concentrations of bioactive polyphenols compared with refined oils, where heat and chemical extraction strip or degrade these compounds. Robust, peppery-tasting oils typically indicate higher phenolic content—a sensory characteristic linked to greater antioxidant capacity.
Based on current evidence, consuming 20–30 grams of extra virgin olive oil daily (approximately 2–3 tablespoons) appears sufficient to achieve the EFSA-approved health claim threshold of 5 milligrams of hydroxytyrosol daily. To maximize intake consistency, incorporate olive oil into salad dressings, drizzle it over cooked vegetables, or use it to finish dishes after cooking rather than during high-heat preparation, which degrades heat-sensitive polyphenols.
Participants consuming approximately 30 grams of olive oil daily experienced 28% lower cancer mortality and 18% lower all-cause mortality over 12 years of follow-up, independent of overall diet quality and lifestyle factors.
— Moli-Sani Study investigators (prospective Italian cohort, 12-year follow-up)
What this means
Frequently asked questions
How much olive oil should I consume daily to achieve the EFSA health claim?
The European Food Safety Authority specifies that 20 grams (approximately 1.5 tablespoons) of olive oil containing at least 5 milligrams of hydroxytyrosol and related compounds per dose meets the evidence threshold for LDL protection. In the Moli-Sani Study, participants consuming approximately 30 grams daily experienced the greatest mortality reductions, suggesting that intake in the 20–30 gram range optimizes benefits.
Does refined olive oil provide the same benefits as extra virgin?
No. Refined olive oils lose most of their polyphenolic compounds during processing through heat, chemical extraction, and bleaching. Extra virgin, cold-pressed varieties retain 5–10 times higher polyphenol concentrations and are specifically required to meet EFSA health claims. Select oils labeled “extra virgin” and stored in dark bottles to prevent light-induced polyphenol degradation.
Can olive oil supplements provide equivalent benefits to whole oil consumption?
Standardized olive oil polyphenol supplements may help achieve consistent dosing of hydroxytyrosol, but whole extra virgin olive oil consumption remains the evidence-based primary recommendation. The Moli-Sani Study and other prospective cohorts used dietary intake rather than supplements, so the strongest epidemiological evidence supports consuming whole olive oil as part of regular meals.
As evidence from large prospective cohorts and mechanistic studies continues to accumulate, olive oil’s role in preventive nutrition becomes increasingly clear. The convergence of epidemiological, biochemical, and regulatory evidence from the EFSA suggests that daily consumption of 20–30 grams of extra virgin olive oil warrants integration into public health dietary guidelines. Future research examining polyphenol dose-response relationships and individual variation in polyphenol absorption may refine recommendations further, but current evidence supports olive oil as one of the most evidence-substantiated functional foods in modern nutrition science.
Source: Moli-Sani Study cohort analysis: olive oil consumption and long-term mortality outcomes
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
